| NCT ID | NCT07878624 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Bordeaux |
| Condition | Addiction |
| Study Type | OBSERVATIONAL |
| Enrollment | 120 participants |
| Start Date | 2025-10-28 |
| Primary Completion | 2029-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 120 participants in total. It began in 2025-10-28 with a primary completion date of 2029-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Addiction is a psychiatric disorder associated with craving, an unwanted, intense and persistent desire to use the substance/addictive behavior, leading to frequent relapses. Craving is fluctuating, influenced by internal factors or environmental context, and can be evaluated only by self-report which can be burdensome. It has been shown that craving predicts relapse, making it a major treatment target in addiction. Identify biomarkers of craving could enable to detect craving in a passive way (without major effort from individuals to report it) and would be a major improvement. The goal of this observational study is to explore if voice could be a biomarker of craving in adults with substance or behavioral addictions. The main question it aims to answer is: • Is there voice features associated with craving episodes in addiction ? Participants will undergo a cue-reactivity protocol with different voice tasks, and then answer Ecological Momentary Assessment (EMA) questionnaires on smartphone, with some of the questionnaires recorded out loud with the smartphone's microphone.
Eligibility Criteria
Inclusion Criteria: * Identify at least one main problematic substance (cannabis, tobacco, alcohol, opiates, stimulant) or one main problematic addictive behavior (e.g : video games, gambling, food, sex…) as the primary addiction * PresentDiagnostic and Statistical Manual of Mental Disorders Fifth Edition (DSM-5) diagnosis for current Use Disorder for this primary addiction * Report regular craving and use of this primary addiction (more than 10 days in the last 30 days) * For participants recruited in treatment centers: receive outpatient treatment for this primary addiction
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07878624 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Addiction. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07878624 currently recruiting?
Yes, NCT07878624 is actively recruiting participants. Contact the research team at fuschia.serre@u-bordeaux.fr for enrollment information.
Where is the NCT07878624 trial being conducted?
This trial is being conducted at Bordeaux, France.
Who is sponsoring the NCT07878624 clinical trial?
NCT07878624 is sponsored by University of Bordeaux. The trial plans to enroll 120 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.